Premium
Injury‐Related Factors and Conditions Down‐Regulate the Thrombin Receptor (PAR‐1) in a Human Neuronal Cell Line
Author(s) -
Weinstein Jonathan R.,
Lau Alice L.,
Brass Lawrence F.,
Cunningham Dennis D.
Publication year - 1998
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1046/j.1471-4159.1998.71031034.x
Subject(s) - receptor , thrombin , internalization , protease activated receptor , thrombin receptor , cell culture , protein kinase c , microbiology and biotechnology , biology , protease activated receptor 2 , biochemistry , signal transduction , 5 ht5a receptor , platelet , immunology , genetics
Previous studies have demonstrated that thrombin can induce potent effects on neural cell morphology, biochemistry, and viability. Nearly all of these effects are mediated by proteolytic activation of the thrombin receptor (PAR‐1). Mechanisms of PAR‐1 regulation in several nonneural cell types have been shown to be novel and cell type specific; however, little is known about PAR‐1 regulation in neural cells. In the present study, PAR‐1 cell surface expression and regulation were examined in a transformed retinoblast (Ad12 HER 10) cell line using radioiodinated anti‐PAR‐1 monoclonal antibodies ATAP2, which recognizes intact and cleaved receptors, and SPAN12, which is specific for the intact form of the receptor. Scatchard analysis revealed high‐affinity, specific binding to a single affinity class of receptors: K D = 3.13 and 5.25 n M , B max = 190.1 and 67.8 fmol/mg of protein for 125 I‐ATAP2 and 125 I‐SPAN12, respectively. Specificity for PAR‐1 was confirmed by demonstrating rapid and near complete decreases for both antibodies following treatment with thrombin or PAR‐1 activating peptide (SFLLRN). Differential antibody binding was used to demonstrate rapid and near complete thrombin‐induced PAR‐1 cleavage and internalization, with protein synthesis‐dependent replacement of intact receptors occurring over longer time intervals, but only minimal recycling of cleaved receptors. A variety of factors and conditions were screened for their effects on PAR‐1 expression. Significant decreases in PAR‐1 expression were induced by the protein kinase C activator phorbol 12‐myristate 13‐acetate (87% at 3 h), the phospholipid inflammatory mediator lysophosphatidic acid (32% at 3 h), and the injury‐related condition hypoglycemia (64 and 100% at 24 h in the absence and presence of dibutyryl cyclic AMP, respectively). The effect of hypoglycemia was shown by RNase protection to be at least partially pretranslational. Finally, thrombin's ability to enhance hypoglycemia‐induced cell killing correlated temporally with PAR‐1 cell surface expression.